IHE:ARCA-iShares U.S. Pharmaceutical

ETF | Health | NYSE Arca

Last Closing Price

USD 159.45

Change

-0.97 (-0.60)%

Market Cap

USD 0.57B

Volume

0.05M

Yahoo Analyst Target

N/A

STA Analyst Target

N/A
Yahoo Analyst Rating

N/A

STA Analyst Rating

N/A

STA Verdict

Verdict

About

The investment seeks to track the investment results of Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying fund measures the performance of the pharmaceuticals sector of the U.S. equity market and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

Inception Date: 01/05/2006

Primary Benchmark: DJ US Select Pharms TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.44%

Management Expense Ratio: 0.44 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-01-16 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV SPDR Select Sector Fund - Heal.. 0.14 %

+0.43 (+0.50%)

USD 17.56B
VHT Vanguard Health Care 0.10 %

+0.25 (+0.15%)

USD 7.51B
XBI SPDR Series Trust S&P Biotech 0.35 %

-2.78 (-3.10%)

USD 4.61B
IYH iShares U.S. Healthcare 0.44 %

+0.62 (+0.34%)

USD 2.04B
IXJ iShares Global Healthcare 0.48 %

+0.06 (+0.05%)

USD 1.70B
IHI iShares U.S. Medical Devices 0.44 %

-0.58 (-0.32%)

USD 1.58B
FBT First Trust Amex Biotech Index.. 0.56 %

-2.94 (-2.22%)

USD 1.28B
FXH First Trust Health Care AlphaD.. 0.62 %

-0.34 (-0.46%)

USD 1.04B
HQH Tekla Healthcare Investors 0.00 %

-0.10 (-0.42%)

USD 0.97B
FHLC Fidelity MSCI Health Care Inde.. 0.08 %

+0.09 (+0.21%)

USD 0.97B

ETFs Containing IHE

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.28% 25% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.28% 25% F 62% D-
Trailing 12 Months  
Capital Gain 10.00% 21% F 55% F
Dividend Return 1.45% 54% F 19% F
Total Return 11.44% 7% F 51% F
Trailing 5 Years  
Capital Gain 76.62% 35% F 75% C
Dividend Return 8.79% 50% F 23% F
Total Return 85.41% 15% F 73% C
Average Annual (5 Year Horizon)  
Capital Gain 11.87% 61% D- 79% C+
Dividend Return 13.04% 50% F 77% C+
Total Return 1.18% 57% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 19.18% 43% F 39% F
Risk Adjusted Return 68.00% 43% F 60% D-
Market Capitalization 0.69B 54% F 44% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.